Provided by Tiger Fintech (Singapore) Pte. Ltd.

Carisma Therapeutics

0.2152
-0.0027-1.24%
Volume:281.67K
Turnover:61.97K
Market Cap:8.99M
PE:-0.15
High:0.2285
Open:0.2179
Low:0.2058
Close:0.2179
Loading ...

Carisma Therapeutics Appoints Interim VP of Finance

TIPRANKS
·
27 Dec 2024

Carisma Therapeutics Inc: on Dec 24, Appoints Natalie Mcandrew as Principal Financial Officer

THOMSON REUTERS
·
27 Dec 2024

HC Wainwright Downgrades Carisma Therapeutics to Neutral From Buy

MT Newswires Live
·
16 Dec 2024

Carisma Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
16 Dec 2024

Carmila SAS (CARM) Receives a Buy from Kepler Capital

TIPRANKS
·
14 Dec 2024

Carisma investors should ‘stay the course,’ says D. Boral Capital

TIPRANKS
·
13 Dec 2024

Baird Downgrades Carisma Therapeutics to Neutral From Outperform, Adjusts Price Target to $1 From $10

MT Newswires Live
·
12 Dec 2024

Carisma Therapeutics Cut to Neutral From Outperform by Baird

Dow Jones
·
12 Dec 2024

Carisma Therapeutics (CARM) was downgraded to a Hold Rating at BTIG

TIPRANKS
·
12 Dec 2024

Carisma Therapeutics downgraded to Neutral from Outperform at Baird

TIPRANKS
·
12 Dec 2024

Carisma Therapeutics: Hold Rating Amid Strategic Shift and Uncertain Pipeline Prospects

TIPRANKS
·
12 Dec 2024

U.S. RESEARCH ROUNDUP- Altus Power, Marsh & Mclennan, TPI Composites

Reuters
·
12 Dec 2024

Carisma Therapeutics Inc : Baird Cuts to Neutral Rating; Cuts Target Price to $1 From $10

THOMSON REUTERS
·
12 Dec 2024

Carisma Therapeutics Cut to In-Line From Outperform by Evercore ISI Group

Dow Jones
·
12 Dec 2024

Carisma Therapeutics (CARM) Receives a Hold from Evercore ISI

TIPRANKS
·
11 Dec 2024

Carisma Therapeutics Cut to Neutral From Buy by BTIG

Dow Jones
·
11 Dec 2024

BTIG Downgrades Carisma Therapeutics to Neutral From Buy

MT Newswires Live
·
10 Dec 2024

Carisma Therapeutics Inc : Btig Cuts to Neutral From Buy

THOMSON REUTERS
·
10 Dec 2024

Carisma Therapeutics downgraded to Neutral from Buy at BTIG

TIPRANKS
·
10 Dec 2024

Carisma Therapeutics price target lowered to $12 from $24 at D. Boral Capital

TIPRANKS
·
10 Dec 2024